Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors

被引:10
|
作者
Namoto, Kenji [1 ]
Sirockin, Finton [1 ]
Sellner, Holger [1 ]
Wiesmann, Christian [1 ]
Villard, Frederic [1 ]
Moreau, Robert J. [2 ]
Valeur, Eric [1 ,3 ]
Paulding, Stephanie C. [1 ]
Schleeger, Simone [1 ]
Schipp, Kathrin [1 ]
Loup, Joachim [1 ]
Andrews, Lori [2 ]
Swale, Ryann [2 ]
Robinson, Michael [2 ]
Farady, Christopher J. [1 ]
机构
[1] Novartis Inst BioMed Res, Novartis Campus, CH-4002 Basel, Switzerland
[2] Novartis Inst BioMed Res, 5300 Chiron Way, Emeryville, CA 94608 USA
[3] AstraZeneca, IMED Biotech Unit, Med Chem Cardiovasc & Metab Dis, Gothenburg, Sweden
关键词
Rhinovirus 3C protease; Protease inhibition; Covalent inhibitor; Macrocycle; Structure-based drug design; Solid phase synthesis; VITRO ANTIVIRAL ACTIVITY; BIOLOGICAL EVALUATION; DISCOVERY;
D O I
10.1016/j.bmcl.2018.01.064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design and synthesis of macrocyclic inhibitors of human rhinovirus 3C protease is described. A macrocyclic linkage of the P1 and P3 residues, and the subsequent structure-based optimization of the macrocycle conformation and size led to the identification of a potent biochemical inhibitor 10 with sub-micromolar antiviral activity. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:906 / 909
页数:4
相关论文
共 50 条
  • [21] Recent advances in the development of human rhinovirus 3C protease inhibitors
    Dragovich, PS
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (02) : 177 - 184
  • [22] Small peptidic aldehyde inhibitors of human rhinovirus 3C protease
    Shepherd, TA
    Cox, GA
    McKinney, E
    Tang, J
    Wakulchik, M
    Zimmerman, RE
    Villarreal, EC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (23) : 2893 - 2896
  • [23] Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis C NS3-4A protease using structure-based drug design
    Venkatraman, S
    Njoroge, FG
    Girijavallabhan, VM
    Madison, VS
    Yao, NH
    Prongay, AJ
    Butkiewicz, N
    Pichardo, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5088 - 5091
  • [24] Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors
    Im, Isak
    Lee, Eui Seung
    Choi, Soo Jeong
    Lee, Ju-Yeon
    Kim, Yong-Chul
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3632 - 3636
  • [25] Formal Synthesis of the Human Rhinovirus 3C Protease Inhibitor (-)-Thysanone
    Mulay, Sandip V.
    Gholap, Sachin P.
    Fernandes, Rodney A.
    ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2015, 4 (06) : 560 - 566
  • [26] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: Structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics
    Dragovich, PS
    Prins, TJ
    Zhou, R
    Johnson, TO
    Brown, EL
    Maldonado, FC
    Fuhrman, SA
    Zalman, LS
    Patick, AK
    Matthews, DA
    Hou, XJ
    Meador, JW
    Ferre, RA
    Worland, ST
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) : 733 - 738
  • [27] Structure-based design and synthesis of aspartyl protease inhibitors
    Ghosh, AK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2642 - U2642
  • [28] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics
    Dragovich, PS
    Prins, TJ
    Zhou, R
    Johnson, TO
    Hua, Y
    Luu, HT
    Sakata, SK
    Brown, EL
    Maldonado, FC
    Tuntland, T
    Lee, CA
    Fuhrman, SA
    Zalman, LS
    Patick, AK
    Matthews, DA
    Wu, EY
    Guo, M
    Borer, BC
    Nayyar, NK
    Moran, T
    Chen, LJ
    Rejto, PA
    Rose, PW
    Guzman, MC
    Dovalsantos, EZ
    Lee, S
    McGee, K
    Mohajeri, M
    Liese, A
    Tao, JH
    Kosa, MB
    Liu, B
    Batugo, MR
    Gleeson, JPR
    Wu, ZP
    Liu, J
    Meador, JW
    Ferre, RA
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (21) : 4572 - 4585
  • [29] Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
    Matthews, DA
    Dragovich, PS
    Webber, SE
    Fuhrman, SA
    Patick, AK
    Zalman, LS
    Hendrickson, TF
    Love, RA
    Prins, TJ
    Marakovits, JT
    Zhou, R
    Tikhe, J
    Ford, CE
    Meador, JW
    Ferre, RA
    Brown, EL
    Binford, SL
    Brothers, MA
    DeLisle, DM
    Worland, ST
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11000 - 11007
  • [30] Non-covalent inhibitors of rhinovirus 3C protease
    Baxter, Andrew
    Chambers, Mark
    Edfeldt, Fredrik
    Edman, Karl
    Freeman, Adrian
    Johansson, Cristian
    King, Sarah
    Morley, Andy
    Petersen, Jens
    Rawlins, Phil
    Spadola, Loredana
    Thong, Bob
    Van de Poel, Herve
    Williams, Nicola
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 777 - 780